Showing results (531-540 of 782) with videos related to
Sort By:
Pageof 79
Cancer Research|September 5, 2002
Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine modelRichard LeBlanc, Laurence P Catley, Teru Hideshima, et al.Blood|September 13, 2003
Identification of genes modulated in multiple myeloma using genetically identical twin samplesNikhil C Munshi, Teru Hideshima, Daniel Carrasco, et al.British Journal of Haematology|December 18, 2012
Endothelial stress products and coagulation markers in patients with multiple myeloma treated with lenalidomide plus dexamethasone: an observational studyRachel Rosovsky, Fangxin Hong, Deanna Tocco, et al.Cancer Management and Research|September 8, 2012
Lenalidomide for the treatment of relapsed and refractory multiple myelomaNiels Wcj van de Donk, Güllü Görgün, Richard Wj Groen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2009
Prognostic significance of copy-number alterations in multiple myelomaHervé Avet-Loiseau, Cheng Li, Florence Magrangeas, et al.Proceedings of the National Academy of Sciences of the United States of America|October 23, 2002
Molecular sequelae of proteasome inhibition in human multiple myeloma cellsNicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.Cancer Immunology, Immunotherapy : CII|June 27, 2012
Lenalidomide enhances anti-myeloma cellular immunityKatarina Luptakova, Jacalyn Rosenblatt, Brett Glotzbecker, et al.Bone|January 22, 2013
In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myelomaSamantha Pozzi, Mariateresa Fulciniti, Hua Yan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2014
Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapyChirayu G Patel, Andrew J Yee, Tyler A Scullen, et al.Haematologica|September 28, 2014
Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myelomaMeletios A Dimopoulos, Robert Z Orlowski, Thierry Facon, et al.Pageof 79